Profitability Ratios
| Ratio |
Value |
| GP Margin |
81.3% |
| EBIT Margin |
29.9% |
| EBITDA Margin |
33.8% |
| Operating Margin |
38.9% |
| Pretax Margin |
28.2% |
| Cont. Ops Margin |
23.5% |
| Net Margin |
23.5% |
| Bottom Line Margin |
23.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.15 |
| Quick Ratio |
0.89 |
| Solvency Ratio |
0.192 |
| Cash Ratio |
0.12 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
65.65 |
| PEG Ratio |
0.65 |
| Forward PEG |
0.65 |
| Price/Book |
48.99 |
| Price/Sales |
15.44 |
| Price/FCF |
1678.17 |
| Price/Op Cash Flow |
78.85 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4274 |
| Debt/Equity |
2.3706 |
| Debt/Capital |
0.7033 |
| Long-Term Debt/Capital |
0.6678 |
| Financial Leverage |
5.55 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
32.21 |
| Operating Cash Flow Ratio |
0.311 |
| Operating Cash Flow/Sales |
19.6% |
| Free Cash Flow/Operating Cash Flow |
4.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.23 |
| Interest Coverage |
22.4208 |
| Short-Term Operating Cash Flow Coverage |
1.72 |
| Operating Cash Flow Coverage |
0.26 |
| Capital Expenditure Coverage |
1.05 |
| Dividend + Capital Expenditure Coverage |
0.67 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
44.1964% |
| Dividend Yield |
0.6732% |
| Dividend Yield % |
0.6732% |
| Dividend Per Share |
5.1970 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
50.01 |
| EPS |
11.759 |
| Debt/Share |
38.2241 |
| Cash/Share |
3.80 |
| Book Value/Share |
15.85 |
| Tangible BV/Share |
2.59 |
| Equity/Share |
15.76 |
| Operating Cash Flow/Share |
9.791 |
| Capital Expenditure/Share |
9.331 |
| FCF/Share |
0.460 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.835 |
| Earnings Before Tax/EBIT |
0.725 |
| Price/Fair Value |
48.99 |
| Debt/Market Cap |
0.0484 |
| Effective Tax Rate |
16.5% |
| Enterprise Value Multiple |
47.65 |
LLY - Eli Lilly and Company